AI assistant
CVS HEALTH Corp — Director's Dealing 2011
Sep 6, 2011
29875_dirs_2011-09-06_e7caac56-c57a-4dc8-a0ee-ed446773df7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2011-09-01
Reporting Person: Roberts Jonathan C (EVP & COO, Caremark)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-01 | Common Stock | M | 48000 | $22.445 | Acquired | 66611.9506 | Direct |
| 2011-09-01 | Common Stock | S | 48000 | $36.01 | Disposed | 18611.9506 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-09-01 | Stock Option | $22.445 | M | 48000 | Disposed | 2012-01-05 | Common Stock (48000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 54944 | Direct |
| ESOP Common Stock | 4942.4291 | Indirect |
| Stock Unit | 21437.1417 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (1441.2722) | 1441.2722 | Direct | |
| Stock Option | $30.035 | 2013-04-03 | Common Stock (64546) | 64546 | Direct |
| Stock Option | $34.42 | 2014-04-02 | Common Stock (60484) | 60484 | Direct |
| Stock Option | $41.17 | 2015-04-01 | Common Stock (86487) | 86487 | Direct |
| Stock Option | $28.10 | 2016-04-01 | Common Stock (101708) | 101708 | Direct |
| Stock Option | $36.23 | 2017-04-01 | Common Stock (61196) | 61196 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (85743) | 85743 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $35.81 and $36.25 per share.
F3: Option became exercisable in three annual installments, commencing 1/5/2006.
F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5: Option became exercisable in three annual installments, commencing 4/3/2007.
F6: Option became exercisable in three annual installments, commencing 4/2/2008.
F7: Option became exercisable in three annual installments, commencing 4/1/2009.
F8: Option became exercisable in three annual installments, commencing 4/1/2010.
F9: Option became exercisable in three annual installments, commencing 4/1/2011.
F10: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.